Telix Adds Lead-212 Isotope Production Capability
MELBOURNE,Australia and INDIANAPOLIS,March 13,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) today announces that it has developed and validated a breakthrough generato
Finance
Digital Grid Platform Achieves Breakthrough in Online Theoretical Line Loss Calculation Technology
Recently, the "Digital Grid" Platform, developed by State Grid Information & Communication Industry Group Co., Ltd. (SGICT), achieved China's first online precise calculation of theoretical line losses across full voltage classes through multi-source data fusion at municipal level, marking a new stage in intelligent line loss management for China's power grid.
Apartment Hotel MIMARU's "Travel Style Finder" Unlocks Ideal Trips to Japan, Making Travel Planning Fun and Easy
TOKYO,March 11,2025-- Cosmos Hotel Management Co.,Ltd.,which operates MIMARU apartment hotels,launched the "Travel Style Finder" on February 26,2025,in line with a website renewal. The Trave
PUBLICIS SAPIENT ANNOUNCES GLOBAL STRATEGIC COLLABORATION AGREEMENT WITH AMAZON WEB SERVICES TO ACCELERATE ENTERPRISE IT MODERNIZATION
Publicis Sapient will leverage AWS\'s advanced generative AI services to help enterprises accelerate their digital business transformation journeys and more easily build personalized campaigns and ex
GameAbove Sports Joins NBL Legend to Inspire Youth
With the power of GameAbove Sports,Bruton,a long-time Australia basketball ambassador,can expand his successful Bruton Basketball Foundation.
SK Networks Collaborates with Qualcomm, Anticipating AI Business Synergy
Plans to IntegrateQualcomm\'s High-Performance IoT Solutions Across Headquarters and Subsidiary Products,Expanding Collaborative Efforts
WuXi XDC and AbTis Announce Strategic Partnership to Advance Next-Generation ADCs
SHANGHAI and SEOUL,South Korea,March 11,2025-- WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company",stock code: 2268.HK),a leading global CRDMO (Contract Research,Development,and Manu
Ascletis Announces Positive Topline Results of Phase Ib Studies of ASC47 Monotherapy in Australia and U.S. FDA Clearance of IND Application for ASC47 in Combination with Semaglutide
ASC47,an adipose-targeted muscle-preserving weight loss drug candidate for the treatment of obesity,demonstrated a half-life of up to 26 days and 40 days,respectively,in Phase Ib single subcutaneous i
Customer Intelligence Summit Singapore, 8 April 2025 at Marina Bay Sands
Empowering Intelligence: Data-Driven,Customer-Centric,Future-Ready SINGAPORE,March 11,2025-- We are thrilled to announce the inauguralCustomer Intelligence Summitin Singapore. This groundbreaking even
From Underground to Cloud: A Panoramic View of the Intelligent Applications Across Multiple Fields Enabled by Algorithmic Innovation
SHENZHEN,China,March 11,2025-- A news report from 6300: In the digital age,the exponential growth of data has intensified the demand for efficient computing across various fields. TheCUDA-accelerated